US Patent Issued to Amgen on Feb. 4 for "Methods of treatment of arthritis and/or psoriasis with pharmaceutical formulations of etanercept" (California Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,214,013, issued on Feb. 4, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Methods of treatment of arthritis and/or psoriasis with pharmaceutical formulations of etanercept" was invented by Monica Goss (Newbury Park, Calif.) and Nicole Ball (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the formulation of pharmaceutical compositions of etanercept. The invention also relates to methods of removing buffer and of formulating pharmaceutical compositions of etanercept."

The patent was filed on Sept. 16, 2022, under Application No. 17/933,055.

*For further information, including images, charts and tables, ...